Statins and venous thromboembolism: do they represent a viable therapeutic agent? - Wikidata - awgldk - TriplyDB

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

http://www.wikidata.org/entity/Q39445730

about

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

http://www.wikidata.org/entity/Q39445730

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

@en

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

@nl

type

label

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

@en

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

@nl

prefLabel

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

@en

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

@nl

P1433

Q39445730-E3E814F7-7459-45B7-BF15-DA3194B11D83

P1476

Q39445730-D6488F42-148A-46BC-9397-3694E53A8ED9

P2093

Q39445730-598C5C63-80F5-4A18-BC8B-62944A21CE62

P2860

Q39445730-0146BDFC-CBAC-4216-A2F4-0E89E3D553BA

Q39445730-026EEE53-E418-41A0-82F3-1D498AE16268

Q39445730-07B68E48-DC95-4678-A2D7-D4BCCEAB1587

Q39445730-09AA5F56-2DC1-404F-9C23-7CD33A53BAB4

Q39445730-0D541D57-26C0-4902-AD6C-2CDE7F435BE8

Q39445730-1A53566A-7A66-4043-B04B-7C8BD7B070EB

Q39445730-1DB1C45F-422D-4819-B7E1-6D927524259A

Q39445730-20355122-186F-4787-8F7D-5A2975319337

Q39445730-20E58B44-9D5C-4208-AF3E-69214429E825

Q39445730-23A3BED1-D374-42B7-966E-491D9197C969

P304

Q39445730-348790A3-3809-426E-AB4B-33B78B41D9B3

P31

Q39445730-1A16D71D-B449-4A02-A226-662572406BED

P356

Q39445730-3BC670C1-6B8A-424E-8814-C31CF9045CA0

P433

Q39445730-7A1D094B-0C33-4804-B5E7-9FC61831253F

P478

Q39445730-FC16DDCD-7270-461B-BF0D-84AACC5B75C8

P50

Q39445730-924BA5AF-8F3E-4B76-9A8B-BF2BA14D7BBB

Q39445730-EB51F275-F76D-453B-904F-97D5CC99FD3D

Q39445730-F2130367-8896-4BB0-AA17-C1EF5FCC6E67

P577

Q39445730-95CBC3B1-78A4-4DB0-8A93-385B076A15C9

P698

Q39445730-E8D376A2-F922-48B6-B5ED-C9E248D20BBF

P921

Q39445730-DF1878A6-E042-4DCA-A794-E0006F6DB73D

P356

14779072.2017.1357468

P1433

Expert Review of Cardiovascular Therapy

P1476

Statins and venous thromboembolism: do they represent a viable therapeutic agent?

@en

P2093

Ashley W Blom

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study

Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Oral rivaroxaban for symptomatic venous thromboembolism

P304

629-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14779072.2017.1357468

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Jari A. Laukkanen

Michael R. Whitehouse

Setor K Kunutsor

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28724320

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism